Neogenomics Ratios (2010-2026) | NEO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	43.53%	38.93%	35.99%	32.63%	35.14%	37.97%	40.97%	39.95%	40.77%	41.01%	43.45%	41.90%	44.07%	44.62%	44.92%	43.59%	42.61%	42.84%	43.83%	43.32%
EBT Margin (Quarter)	60.33%	-19.10%	-35.16%	-45.37%	-32.81%	-30.77%	-18.40%	-24.57%	-18.13%	-14.12%	-9.83%	-17.72%	-11.56%	-10.64%	-9.38%	-15.27%	-25.27%	-14.05%	-6.52%	-9.42%
EBIT Margin (Quarter)	-18.38%	-32.73%	-33.06%	-44.40%	-31.74%	-30.68%	-19.02%	-25.56%	-20.35%	-15.92%	-11.94%	-19.56%	-13.34%	-12.63%	-10.70%	-16.56%	-26.27%	-14.38%	-7.05%	-9.77%
EBITDA Margin (Quarter)	-18.38%	-32.73%	-33.06%	-44.40%	-31.74%	-30.68%	-19.02%	-25.56%	-20.35%	-15.92%	-11.94%	-19.56%	-13.34%	-12.63%	-10.70%	-16.56%	-26.27%	-14.38%	-7.05%	-9.77%
Operating Margin (Quarter)	-18.38%	-32.73%	-33.06%	-44.40%	-31.74%	-30.68%	-19.02%	-25.56%	-20.35%	-15.92%	-11.94%	-19.56%	-13.34%	-12.63%	-10.70%	-16.56%	-26.27%	-14.38%	-7.05%	-9.77%
Net Margin (Quarter)	62.33%	-16.77%	-33.21%	-42.17%	-28.23%	-28.62%	-16.36%	-22.44%	-16.56%	-12.19%	-9.21%	-17.32%	-11.33%	-10.55%	-8.91%	-15.43%	-24.87%	-14.45%	-5.20%	-9.16%
FCF Margin (Quarter)	-29.98%	-18.74%	-25.26%	-31.80%	-21.82%	-18.73%	15.13%	-10.10%	-12.11%	7.43%	11.45%	-20.16%	0.49%	-0.93%	22.24%	-17.75%	7.72%	0.30%	9.87%	-7.04%
Efficiency
Inventory Average (Quarter)	21.38M	21.61M	22.61M	23.62M	22.85M	22.83M	24.04M	24.35M	24.69M	24.50M	24.10M	22.24M	21.77M	23.84M	25.60M	28.26M	31.97M	31.32M	28.51M	29.20M
Assets Average (Quarter)	1,695.36M	1,901.35M	1,888.08M	1,849.66M	1,810.83M	1,773.85M	1,747.81M	1,724.60M	1,702.14M	1,686.67M	1,679.73M	1,660.78M	1,641.81M	1,642.19M	1,639.57M	1,619.73M	1,497.69M	1,384.37M	1,367.31M	1,353.18M
Equity Average (Quarter)	996.04M	1,142.80M	1,122.76M	1,091.64M	1,059.26M	1,028.25M	1,005.51M	986.24M	965.33M	951.81M	944.48M	932.47M	919.65M	912.05M	905.27M	895.30M	871.15M	846.16M	837.43M	832.66M
Invested Capital (Quarter)	1,148.36M	1,137.24M	1,108.28M	1,075.00M	1,043.52M	1,012.99M	998.02M	974.46M	956.19M	947.43M	941.54M	923.41M	915.88M	908.21M	902.34M	888.27M	854.04M	838.29M	836.56M	828.76M
Asset Utilization Ratio (Quarter)	0.29	0.25	0.26	0.26	0.27	0.28	0.29	0.31	0.32	0.34	0.35	0.37	0.38	0.39	0.40	0.42	0.46	0.51	0.53	0.55
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-24.80	-30.64	-8.58	-39.99	-42.87	-284.24	-5.06	-19.96	-16.76	-14.36	-11.05	-18.14	-13.17	-12.91	-11.33	-17.20	-51.05	-44.80	-22.39	-30.50
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)	0.61	0.60	0.59	0.59	0.58	0.58	0.57	0.57	0.56	0.56	0.56	0.56	0.56	0.55	0.55	0.55	0.61	0.61	0.62	0.62
Times Interest Earned (Quarter)	-24.80	-30.64	-8.58	-39.99	-42.87	-284.24	-5.06	-19.96	-16.76	-14.36	-11.05	-18.14	-13.17	-12.91	-11.33	-17.20	-51.05	-44.80	-22.39	-30.50
Valuation
Enterprise Value (Quarter)	-571.75M	-542.71M	-515.39M	-481.43M	-465.95M	-443.54M	-437.99M	-417.92M	-409.35M	-402.26M	-415.20M	-384.83M	-387.86M	-387.81M	-386.84M	-358.08M	-163.69M	-164.12M	-159.62M	-146.14M
Return Ratios
Return on Sales (Quarter)	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-1.71%	-3.96%	-6.59%	-8.81%	-10.01%	-10.23%	-9.51%	-8.59%	-8.14%	-7.25%	-6.80%	-6.52%	-7.05%	-6.86%	-6.88%	-6.67%	-8.23%	-9.40%	-9.06%	-8.38%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Neogenomics Ratios (2010-2026) | NEO

Create an account

Sign In

Reset Password